Australia

News

Anthony Albanese at this month's UN event

Australia starts probe into AI infiltration of Medicare

The infiltration of Australia's Medicare by an AI agent raises serious questions about patient privacy and the security of confidential pharma data.

Oncology

Australia, CAR-T therapy, and solid tumours

Bev Menner, chief executive officer at Cell Therapies Pty Ltd, discusses CAR-T therapies for solid tumours and Australian and APAC R&D more generally.

Digital

Australia, AI, and Autolomous

pharmaphorum spoke with Alexander Seyf, CEO of Autolomous, about the future of AI in Australian biotech.

Market Access

Approval designed from day one: Building global-ready regula...

The global pharmaceutical landscape is increasingly defined by the necessity for clinical acceleration without compromising data integrity.

News

Australia stands firm on 'no' to Alzheimer's drug Leqembi

Eisai and Biogen have been unable to persuade Australia's medicines regulator to approve their Alzheimer's therapy Leqembi with a narrower label.

News

Australia joins EU in turning down Alzheimer's drug Leqembi

Australia's Therapeutic Goods Administration (TGA) has said it won't approve Eisai and Biogen's Alzheimer's disease therapy Leqembi, saying its efficacy does not outweigh its risks.

Australia starts probe into AI infiltration of Medicare

Australia, CAR-T therapy, and solid tumours

Australia, AI, and Autolomous

Approval designed from day one: Building global-ready regula...

Australia stands firm on 'no' to Alzheimer's drug Leqembi

Australia joins EU in turning down Alzheimer's drug Leqembi

Iambic prices its IPO, seeking to raise up to $160m

Discover a new era of healthcare panel engagement: Grounded ...

Australia

Editor's Picks